UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CML-216 Incidence and Type of Second Primary Malignancies (SPMs) in Chronic Myeloid Leukemia Patients

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S366-S366

2024

Volltextzugriff (PDF)

CML-585 Mutational Landscape of Tumor Cells in Patients With Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S376-S376

2024

Volltextzugriff (PDF)

CML-610 Mutations of Unknown Significance in the FOXO and EGFR Signaling Pathways in Patients With CML

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S376-S377

2024

Volltextzugriff (PDF)

CML-311 Matching-Adjusted Indirect Comparisons (MAICs) of Asciminib vs Other Tyrosine Kinase Inhibitors (TKIs) in Third- or Later-Line Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S337-S338

2023

Volltextzugriff (PDF)

CML-292 Chronic Myeloid Leukemia Reduces Survival in Elderly Patients (Age ≥ 75 Years Old): An International Multicenter Retrospective Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S335-S335

2023

Volltextzugriff (PDF)

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S349-S350

2023

Volltextzugriff (PDF)

CML-397 Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults: A Single Center Experience

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S339-S340

2023

Volltextzugriff (PDF)

CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S334-S334

2023

Volltextzugriff (PDF)

CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S350-S351

2023

Volltextzugriff (PDF)

Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features

Bionatura, 2022-09, Vol.7 (3), p.1-3

2022

Volltextzugriff (PDF)

CML-216 Hypereosinophilia Syndrome With FIP1L1-PDGFRA Transcript Revealed by Cardiac Involvement

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S290

2022

Volltextzugriff (PDF)

CML-030 Do Patients With CML-CP in MMR Still Have a Hope to Receive Nilotinib (Tasigna) While Fasting During Ramadan? An Unanswered Question

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S284

2022

Volltextzugriff (PDF)

CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22, p.S286-S287

2022

Volltextzugriff (PDF)

CML-558 Genetic Alterations in Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitors Resistance From Guatemala Through Next-Generation Sequencing

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S375-S375

2024

Volltextzugriff (PDF)

CML-053 Health-Related Quality of Life in Macedonian Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: EQ-5D-5L Assessment

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S362-S362

2024

Volltextzugriff (PDF)

CML-073 Smoking and Depression and Hematopoietic Stem Cell Transplantation Outcome

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S363-S363

2024

Volltextzugriff (PDF)

ALL-072 Quality of Life in 74 Recipients of Allogeneic Bone Marrow Transplantation

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S257-S258

2024

Volltextzugriff (PDF)

The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease

Free radical biology & medicine, 2019-05, Vol.135, p.28-37

2019

Volltextzugriff (PDF)

CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S331-S332

2021

Volltextzugriff (PDF)

CML-159: Epidemiological Data on Chronic Myeloid Leukemia (CML) in the Republic of Kosovo During the Period 2015-2019

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S329-S329

2021

Volltextzugriff (PDF)

Managing TKI Resistance: New Options

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S158-S158

Rea, Delphine

2021

Volltextzugriff (PDF)

CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S335-S336

2021

Volltextzugriff (PDF)

EXABS-189-CML European LeukemiaNet Laboratory Recommendations for the Diagnosis and Management of Chronic Myeloid Leukemia

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S84-S85

2023

Volltextzugriff (PDF)

CML-294 Chronic Myeloid Leukemia of the Elderly Over 60 Years: Epidemiological, Cytogenetic, and Therapeutic Profile in CASABLANCA

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S335-S336

2023

Volltextzugriff (PDF)

CML-206 Secondary Chronic Myeloid Leukemia Following Successful Treatment of Metastatic Colon Cancer: A Case Report

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S333-S333

2023

Volltextzugriff (PDF)

1 – 25 von 4.352

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(3.577)
Mit Volltextzugriff
(3.548)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.076)
Cml
(2.904)
Life Sciences & Biomedicine
(2.740)
Humans
(2.270)
Oncology
(1.329)
Hematology
(1.328)
Chronic Myeloid Leukemia
(971)
Male
(948)
Female
(873)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(815)
Adult
(786)
Biological And Medical Sciences
(765)
Middle Aged
(749)
Leukemia
(734)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(724)
Medical Sciences
(703)
Imatinib
(577)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Pathology
(577)
Imatinib Mesylate
(506)
Aged
(479)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(2.381)
EZB Electronic Journals Library
(1.787)
IngentaConnect
(1.650)
Ovid SocietyJournals and Single Titles
(1.347)
Elsevier ScienceDirect Journals Complete
(873)
IngentaConnect Journals
(596)
Wiley Online Library
(560)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(549)
Wiley Online Library Full Collection 2018
(470)
Springer Journals
(465)
Taylor & Francis Journals
(393)
Taylor & Francis
(369)
Taylor & Francis Online
(358)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(342)
IEEE Electronic Library (IEL)
(302)
Nexis Uni
(301)
Publisher or Other Site
(297)
Nature Journals
(270)
Ebook Central Perpetual and DDA
(140)
eBooks on EBSCOhost
(137)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Lymphoma, Myeloma And Leukemia
(226)
Leukemia & Lymphoma
(206)
Leukemia Research
(206)
British Journal Of Haematology
(150)
Leukemia
(130)
Rinsho Ketsueki
(101)
Rinshō Ketsueki
(101)
Bone Marrow Transplantation
(86)
International Journal Of Hematology
(55)
Haematologica
(52)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CML-216 Incidence and Type of Second Primary Malignancies (SPMs) in Chronic Myeloid Leukemia Patients

CML-585 Mutational Landscape of Tumor Cells in Patients With Chronic Myeloid Leukemia

CML-610 Mutations of Unknown Significance in the FOXO and EGFR Signaling Pathways in Patients With CML

CML-311 Matching-Adjusted Indirect Comparisons (MAICs) of Asciminib vs Other Tyrosine Kinase Inhibitors (TKIs) in Third- or Later-Line Chronic Myeloid Leukemia in Chronic Phase (CML-CP)

CML-292 Chronic Myeloid Leukemia Reduces Survival in Elderly Patients (Age ≥ 75 Years Old): An International Multicenter Retrospective Study

CML-590 ASC4START: A Phase 3b, Open-Label, Randomized Study of Asciminib vs Nilotinib in Patients With Newly Diagnosed Ph+ Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

CML-397 Clinical Characteristics and Outcomes of CML in Adolescents and Young Adults: A Single Center Experience

CML-254 Asciminib Management in Chronic Myeloid Leukemia (CML) Patients With T315I Mutation

CML-640 Case Report of Metachronous Ph+ and Ph Myeloproliferative Neoplasms

Chronic Myeloid Leukemia: A retrospective study of clinical and pathological features

CML-216 Hypereosinophilia Syndrome With FIP1L1-PDGFRA Transcript Revealed by Cardiac Involvement

CML-030 Do Patients With CML-CP in MMR Still Have a Hope to Receive Nilotinib (Tasigna) While Fasting During Ramadan? An Unanswered Question

CML-074 Pathogenesis of Tyrosine Kinase Inhibitor–Associated Vascular Toxicity in Chronic Myeloid Leukemia

CML-558 Genetic Alterations in Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitors Resistance From Guatemala Through Next-Generation Sequencing

CML-053 Health-Related Quality of Life in Macedonian Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: EQ-5D-5L Assessment

CML-073 Smoking and Depression and Hematopoietic Stem Cell Transplantation Outcome

ALL-072 Quality of Life in 74 Recipients of Allogeneic Bone Marrow Transplantation

The deglycase activity of DJ-1 mitigates α-synuclein glycation and aggregation in dopaminergic cells: Role of oxidative stress mediated downregulation of DJ-1 in Parkinson's disease

CML-268: Study to Evaluate the Effect of Fatty Meals on Nilotinib Drug Levels in Patients with CML-CP

CML-159: Epidemiological Data on Chronic Myeloid Leukemia (CML) in the Republic of Kosovo During the Period 2015-2019

Managing TKI Resistance: New Options

CML-413: Asciminib Provides Durable Responses and a Favorable Safety Profile in Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) with the T315I Mutation in a Phase 1 Study

EXABS-189-CML European LeukemiaNet Laboratory Recommendations for the Diagnosis and Management of Chronic Myeloid Leukemia

CML-294 Chronic Myeloid Leukemia of the Elderly Over 60 Years: Epidemiological, Cytogenetic, and Therapeutic Profile in CASABLANCA

CML-206 Secondary Chronic Myeloid Leukemia Following Successful Treatment of Metastatic Colon Cancer: A Case Report

Suchergebnisse filtern